ALFA Filings
Every announcement, straight from the exchange
Every Aurobindo Pharma merger & restructuring announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Aurobindo Pharma's subsidiary, Apitoria Pharma, completed a 20% stake dilution in A1 Biochem Labs. Dr. Rajendra Gadikota subscribed to securities worth ₹33.80 Crore.
Aurobindo Pharma's subsidiary, A1 Biochem Labs (India), invested USD 1,000,000 (approx. ₹9.5 Crore) to incorporate and capitalize a new US subsidiary, A1 Biochem USA Inc.
Aurobindo Pharma's subsidiary, Apitoria Pharma, incorporated a new wholly owned subsidiary named Avogent Lifesciences. The initial capital subscription for this pharmaceutical entity is Rs. 5 Crore.
Aurobindo Pharma incorporated a new wholly owned subsidiary, 'Auropharm Overseas Limited'. The company subscribed to the subsidiary's share capital of Rs. 0.1 Crore.
Aurobindo Pharma approved the merger of its wholly-owned step-down subsidiaries, Eugia Steriles and Eugia SEZ, into its wholly-owned subsidiary, Eugia Pharma Specialities, to simplify the group structure.